Recent Updates
Recently added Catalysts

Biotech M&A Tracker

Track biopharma mergers, acquisitions, and predicted takeover targets with deal premiums and therapeutic area analysis.
$942BIndustry FirepowerEY 2026
$136B → $370BGrowth Gap by 2028 (2032)EY Firepower
32Deals YTD
41%Avg Premium
$240B2025 M&A Value

This Week's Movers

last 7 days
  • LGVN24 15 pts
    Fundamental Valuation
  • KRRO29 -14 pts
    Acquirer Demand
  • CYPH50 14 pts
    Acquirer Demand
  • PLX47 13 pts
    Acquirer Demand
  • ARMP22 -9 pts
    SEC Filings

Acquirer Urgency Heatmap

click to drill down
  • MRKMerck10/10
  • BMYBristol-Myers Squibb10/10
  • PFEPfizer8/10
  • BIIBBiogen6/10
  • AMGNAmgen7/10
  • GILDGilead Sciences7/10
  • AZNAstraZeneca6/10
  • NVSNovartis6/10

Recent Deals

latest 5
  • Jul 16Closed
    Jasper Therapeutics, Inc.←Kira Pharmaceuticals
    N/Aimmunology
  • Jul 16Announced
    AtaiBeckley Inc.←Eli Lilly and Company
    $3.8B+26% premneuroscience
    Predicted by BiopharmaWatch
  • Jul 8Announced
    Scipher Medicine Corporation←Chemomab Therapeutics Ltd.
    $150Mimmunology
  • Jul 6Announced
    Myricx Bio←Novartis AG
    $1.5Boncology
  • Jul 6Pending
    Crinetics Pharmaceuticals, Inc.←Vertex Pharmaceuticals Incorporated
    $10.0B+102% premendocrinology
    Predicted by BiopharmaWatch

Top 10 Targets - Probability Leaderboard

#TickerCompanyScoreTierTop Acquirer MatchLead Asset
1TARA70HIGHBMYBIIBJNJ—
2XFOR70HIGHBMYBIIBJNJ—
3REPL67HIGHGILDABBVPFE—
4SNDX67HIGHAZNMRKBMY—
5NUVB67HIGHREGNAZNMRK—